Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
44.61
-2.80 (-5.91%)
At close: Dec 5, 2025, 4:00 PM EST
44.16
-0.45 (-1.01%)
After-hours: Dec 5, 2025, 7:52 PM EST
Veracyte Market Cap
Veracyte has a market cap or net worth of $3.53 billion as of December 5, 2025. Its market cap has increased by 23.95% in one year.
Market Cap
3.53B
Enterprise Value
3.20B
1-Year Change
23.95%
Ranking
Category
Stock Price
$44.61
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $3.53B, an increase of 1,186.53%. That is a compound annual growth rate of 23.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.75B | 22.11% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |